> FDA approves Spravato nasal spray for depression
FDA approves Spravato nasal spray for depression
Clip ID 2429964
Clearance
Add to
Share
Add to Review Link
By Request
By Request assets are not available for immediate purchase.
This content has not been pre-checked for copyright.
Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us
Description
The FDA has approved Spravato, a nasal spray for adults with major depressive disorder, marking the first standalone therapy for treatment-resistant depression.
Subscribe: https://www.youtube.com/c/KGWNews8
Watch the latest KGW newscast: https://www.kgw.com/watch
Get the KGW app: https://kgw.com/appredirect